Alira Health

Industries

MedTech

Fostering sustainable industry growth

From advancing technology and the impacts of value-based healthcare to diversified delivery points and increasingly personalized care, the MedTech industry is evolving—and creating the possibility for growth.

As your partner, we’ll work closely with you to uncover opportunities across the industry, accelerate innovation and deliver tomorrow’s standard of care.

Why choose Alira Health?

Alira Health can help you leverage the potential in the medical device and diagnostic market with our full spectrum of advisory services. You’ll benefit from our:

  • 360° lifecycle approach

    that supports products, technologies, and services from concept ideation to creation and commercialization

  • Regulatory

    clinical, and health expertise in medical affairs strategy and execution

  • Management consulting

    to define growth initiatives and accelerate market penetration. Learn more

  • Global transaction advisory services

    including M&A, licensing, partnering and distribution, and capital raises. Learn more

  • In-depth experience

    across the entire healthcare ecosystem—suppliers, payers, providers, and patients

  • Fully collaborative team

    of bankers, scientists, strategists, and doctors who deliver a holistic view of each project

Areas of expertise

Alira Health teams bring together top talent from every life science and healthcare sector to take your innovation from strategy to reality. Our teams specialize in:
  • Cardiovascular
  • Companion diagnostics
  • Critical care
  • Diabetes
  • Drug and device combination
  • Drug delivery
  • Fluid management
  • Infection control
  • Interventional medicine
  • In vitro diagnostics
  • Medical imaging
  • Minimally invasive surgery
  • Neurovascular
  • Oncology
  • Orthopedics
  • Patient monitoring
  • Precision medicine
  • Robotics
  • Surgical equipment
  • Wearables
  • Wound care

Local insights, global reach

Since 1999, Alira Health has increased value for its pharma, biotech, and MedTech clients around the world. Our local presence and global collaboration combined with our deep domain experience allows us to deliver actionable insights.
20+
Years serving pharma and MedTech clients
80%
Of the top 50 MedTech companies are advised by Alira Health

Working together to humanize healthcare

As your industry evolves, we’re ready to help you lead the way.

Contact us
David Uffer
David Uffer
Senior Partner, Vice President, MedTech
Our integrated approach sets us apart—we bring together experts from across the practice to deliver guidance from strategy to tactical execution.

Explore our related publications:

News September 1, 2026
Alira Health Advises Mindful Capital Partners on the Sale of Portfolio Company Sidam S.r.l. to Plastiflex Group
Alira Health is pleased to have acted as Vendor Due Diligence Advisor to Mindful Capital Partners, an independent cross-border private equity firm focused on mid-market companies across(...)
MedTech
Reports and White Papers September 1, 2026
Global Medtech Contract Development and Manufacturing Market H1 2026 M&A Update
Learn about the H1 2026 M&A trends in the medtech CDMO market including deal activity, geographic distribution of transactions, and target end-markets.
CDMO MedTech
Articles August 19, 2026
How to Develop Global Clinical Evidence Strategies for Regulatory Success in Medtech
Discover how a strategically planned clinical evidence generation strategy can support global device approval, maximize evidence value, and prepare for international expansion.
MedTech Regulatory
Events July 24, 2026
MedTech World Asia 2026
Meet our team at MedTech World Asia 2026 and learn how our integrated model can support your international expansion and drive commercial success.
MedTech
Articles July 24, 2026
How Pharma and Medtech Convergence Is Changing DDS Partner Selection in 2026
Learn how pharma and medtech convergence is reshaping drug delivery system partner selection, from combination products and regulatory readiness to integrated execution.
Drug Delivery MedTech Pharma
Articles April 24, 2026
From Approval to Adoption: A New Framework for Medtech Success
Medtech success requires more than approval. Discover how aligning evidence, patient needs, and market access drives adoption.
Interview MedTech Regulatory
Reports and White Papers March 30, 2026
The 2026 Global Medtech Contract Development and Manufacturing Report
Download this free report now to access the key trends shaping outsourcing strategies, deal activity, and capability development across the industry in 2026.
CDMO MedTech
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.